Literature DB >> 3053052

HLA DR and DQ distribution in normal human ocular structures.

C Baudouin1, D Fredj-Reygrobellet, P Gastaud, P Lapalus.   

Abstract

HLA DR and DQ distribution was investigated in normal human ocular tissues, together with class I antigens and immunocompetent cell subsets, by immunofluorescence and immunoperoxidase procedures. In the anterior segment, our findings, consistent with those of previous reports, showed the wide distribution of class I antigens, specially in the corneal epithelium, while class II antigens were restricted to very rare cells scattered in the conjunctiva, the peripheral cornea and the stroma of the ciliary processes. Some non pigmented epithelial cells of the ciliary processes were HLA DR and DQ positive. In the posterior segment, class I antigens were abundantly represented in the choroid and the retinal layers. Few HLA DR and DQ positive cells were seen in the choroid, similar to those found in the anterior segment. Normal RPE did not react with any monoclonal antibody, but numerous cells located in the retina were strongly HLA DR and DQ positive, all around the blood vessels, and not at the sites of endothelial cells. The characterization of those cells, which could be hypothetized as pericytes needs further studies but suggests close relationships between neuroretina and the immune system. This study may provide insight in the implication of the immune system in many poorly understood ocular diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053052     DOI: 10.3109/02713688808997247

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  The expression of class I major histocompatibility antigens by human retinal pigment epithelium in vitro.

Authors:  M T Benson; L Shepherd; D Cottam; J Lawry; R C Rees; I G Rennie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.

Authors:  S E Coupland; L Krause; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

3.  Induction of MHC class II antigen in cultured bovine ciliary epithelial cells.

Authors:  H Helbig; R C Gurley; R J Reichl; R Mahdi; R B Nussenblatt; A G Palestine
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

4.  Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells.

Authors:  H Helbig; K L Kittredge; A G Palestine; M Coca-Prados; R B Nussenblatt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

5.  Class II major histocompatibility complex (Ia) antigen-bearing dendritic cells within the iris and ciliary body of the rat eye: distribution, phenotype and relation to retinal microglia.

Authors:  P G McMenamin; I Holthouse; P G Holt
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

6.  Identification of a novel macrophage population in the normal mouse corneal stroma.

Authors:  Cynthia S Brissette-Storkus; Stephanie M Reynolds; Andrew J Lepisto; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

7.  Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens.

Authors:  C Baudouin; N Haouat; F Brignole; J Bayle; P Gastaud
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

Review 8.  Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future.

Authors:  Pedram Hamrah; Deborah Pavan-Langston; Reza Dana
Journal:  Int Ophthalmol Clin       Date:  2009

Review 9.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.